AOS vs EBS · P/E 19, rev $3.85B vs rev $1.04B
Smith AO Corporation (AOS) versus Emergent Biosolutions Inc (EBS) — a side-by-side from cached financials, not a winner call.
Smith AO Corporation (AOS) is a specialty industrial machinery company listed on US.
Emergent Biosolutions Inc (EBS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported AOS revenue for 2023-12-31 was $3.85B. Net income was $556.6M. Revenue was up 2.6% from 2022-12-31 to 2023-12-31. AOS currently screens at market cap $9.73B and trailing P/E 19.1.
Latest reported EBS revenue for 2024-12-31 was $1.04B. Net income was -$190.6M. Revenue was down 0.5% from 2023-12-31 to 2024-12-31. EBS currently screens at market cap $416.4M.
AOS currently screens at market cap $9.73B and trailing P/E 19.1. EBS currently screens at market cap $416.4M.
Not investment advice. Open the AOS and EBS stock pages for the full models.
Not investment advice.